How Morningside Pharmaceuticals is preparing for Brexit

Morningside Pharmaceuticals details how it is preparing for Brexit and what other life sciences companies can do to get ready for when the UK leaves the EU.

In the United Kingdom, the company’s products are distributed twice daily to NHS hospitals and pharmacies. Globally, the business is one of the leading medical suppliers to aid agencies, charities and NGOs – including UNICEF, the Red Cross and the World Health Organisation (WHO).

Morningside Pharmaceuticals is one of many small and medium-sized businesses across the country who will need to be ready when the UK leaves the EU. Leaving the EU will bring important changes to the way companies conduct business and it is vital that they are prepared.  

Dr Nik Kotecha OBE, chief executive of Morningside Pharmaceuticals, said: “Preparing to leave the European Union must currently be the number one priority for every UK business.

“It is one of the most challenging issues facing UK companies. My company manufacture and supply quality medicines to the UK and international markets. We stand ready for the changes that will come and want to share our experiences with other UK businesses to help them do the same.”

Dr Nik Kotecha’s top tips for other pharmaceutical businesses to prepare for Brexit include: 

 Visit gov.uk/brexit for tailored business information or to sign up for email updates.  

Back to topbutton